312 related articles for article (PubMed ID: 24821431)
1. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556
[TBL] [Abstract][Full Text] [Related]
3. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH
J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
[TBL] [Abstract][Full Text] [Related]
4. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S
Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498
[TBL] [Abstract][Full Text] [Related]
5. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
6. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
[TBL] [Abstract][Full Text] [Related]
8. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity.
Mittendorfer B; Patterson BW; Klein S
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E549-56. PubMed ID: 12475754
[TBL] [Abstract][Full Text] [Related]
9. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
Watts GF; Chan DC; Barrett PH
Metabolism; 2002 Sep; 51(9):1206-10. PubMed ID: 12200768
[TBL] [Abstract][Full Text] [Related]
11. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.
Chan DC; Watts GF; Gan SK; Ooi EM; Barrett PH
Diabetes Care; 2010 May; 33(5):1134-9. PubMed ID: 20185740
[TBL] [Abstract][Full Text] [Related]
12. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus.
Vergès B; Guiu B; Cercueil JP; Duvillard L; Robin I; Buffier P; Bouillet B; Aho S; Brindisi MC; Petit JM
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3050-7. PubMed ID: 23087360
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
Chan DC; Watts GF; Barrett PH
Diabetes Obes Metab; 2003 May; 5(3):202-6. PubMed ID: 12681028
[TBL] [Abstract][Full Text] [Related]
14. Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state.
Wong AT; Chan DC; Barrett PH; Adams LA; Watts GF
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1427-35. PubMed ID: 24606094
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
[TBL] [Abstract][Full Text] [Related]
16. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM
Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646
[TBL] [Abstract][Full Text] [Related]
18. Effects of moderate exercise on VLDL₁ and Intralipid kinetics in overweight/obese middle-aged men.
Al-Shayji IA; Caslake MJ; Gill JM
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E349-55. PubMed ID: 22094472
[TBL] [Abstract][Full Text] [Related]
19. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
20. One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDL-triglyceride secretion in overweight and obese men.
Smith GI; Magkos F; Reeds DN; Okunade AL; Patterson BW; Mittendorfer B
J Clin Endocrinol Metab; 2013 Aug; 98(8):3454-62. PubMed ID: 23750033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
